Laurus Labs Share Price: Company forays into Lucrative Biotech Space
The acquisition is likely to be positive for Laurus as it highly compliments the company’s aggressive growth plans and also offers a new revenue stream. Laurus’s existing business is also on a strong footing with the formulations segment being a key growth driver. The acquisition of RLPL abates concerns around utilisation of higher cash on Laurus’s books and this bodes well.
Laurus is a Chemistry-based company and does not have any exposure to biology: Reuters